Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
7.36
0.10 (1.38%)
At close: Aug 15, 2025, 3:59 PM
Contineum Therapeutics Class A Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -56.86M | -49.83M | -42.26M | -35.46M | -31.45M | 19.13M | 22.72M | 22.98M | 29.23M | -12.34M | -7.51M |
Depreciation & Amortization | 294K | 275K | 258K | 220K | 201K | 183K | 195K | 239K | 196K | 154K | 81K |
Stock-Based Compensation | 9.53M | 7.73M | 5.93M | 4.44M | 2.62M | 2.49M | 2.22M | 1.95M | 1.47M | 985K | 491K |
Other Working Capital | 1.31M | 932K | 4.19M | -544K | -1.74M | 617K | -1.02M | 1.54M | 1.07M | -900K | 396K |
Other Non-Cash Items | -3.59M | -1.26M | -1.12M | 57K | -135K | -2.54M | -2.31M | -15K | 750K | 2.95M | 2.56M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.19M | 3.98M | 5.33M | -406K | -1.6M | 265K | -1.02M | 2.19M | 1.07M | -595K | 419K |
Operating Cash Flow | -46.44M | -39.28M | -32.98M | -33.49M | -32.7M | 16.48M | 19.35M | 25.98M | 31.35M | -9.32M | -4.08M |
Capital Expenditures | -339K | -414K | -514K | -657K | -597K | -509K | -414K | -105K | -83K | -52K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -185.89M | -229.46M | -226.41M | -194.05M | -173.72M | -163.29M | -141.87M | -132.83M | -80.75M | -22.18M | -12.96M |
Sales Maturities Of Investments | 175.43M | 166.3M | 157.16M | 143.37M | 113.68M | 97.61M | 76.71M | 63.26M | 50.65M | 36.5M | 17.88M |
Other Investing Acitivies | 20K | 20K | 8.9M | 18.24M | 18.22M | 18.22M | 18.75M | 14.32M | 14.32M | 14.32M | 4.92M |
Investing Cash Flow | -10.77M | -63.55M | -69.74M | -51.32M | -60.63M | -66.19M | -65.57M | -69.68M | -30.18M | 14.27M | 4.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -3.13M | -3.75M | -4.38M | -4.38M | -1.25M | -625K |
Common Stock Repurchased | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 770K | 109.04M | 109M | 108.04M | 108.14M | 49.69M | 49.71M | 50.03M | 49.92M | 8K | n/a |
Financial Cash Flow | 770K | 109.04M | 109.14M | 108.18M | 118.49M | 56.91M | 56.18M | 55.87M | 45.55M | -1.24M | -625K |
Net Cash Flow | -56.45M | 6.21M | 6.42M | 23.37M | 25.16M | 7.2M | 9.96M | 12.17M | 46.72M | 3.71M | 215K |
Free Cash Flow | -46.78M | -39.56M | -33.36M | -34M | -33.15M | 15.97M | 18.93M | 25.87M | 31.27M | -9.37M | -4.08M |